4/A: Zura Bio Director Amends Filing to Correct Transaction Code After Private Placement

An amended SEC Form 4 reveals a correction to the transaction code for a Zura Bio director's acquisition of shares in a private placement.

Summary

• Amit Munshi, a director of Zura Bio Ltd, filed an amended Form 4 with the SEC to correct a transaction code error.
• The original filing, dated April 24, 2024, incorrectly used transaction code 'P'.
• The amendment clarifies that the correct transaction code is 'A', indicating an acquisition.
• The transaction involves the acquisition of 159,744 Class A ordinary shares at a price of $3.13 per share on April 22, 2024, through a private placement.
• Following the transaction, Munshi beneficially owns 777,384 Class A ordinary shares.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing correcting an error. It doesn't contain significant positive or negative news, but the director's increased stake could be viewed slightly positively.

Positives

• The director's increased stake in the company could be seen as a positive signal.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, ensuring transparency and compliance with SEC regulations.

Stakeholder Impact

• The correction of the filing ensures accurate information for shareholders and potential investors.

Key Dates